Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags

Author(s):  Kaiser Jeanette, Kramer Irene

Issue:  Nov/Dec 2011 - Volume 15, Number 6
View All Articles in Issue

Page(s):  515-520

Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 1
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 2
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 3
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 4
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 5
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Page 6

Download in electronic PDF format for $65

Abstract:  The purpose of this study was to determine the physicochemical stability of ready-to administer trastuzumab infusion solutions in 0.9% sodium chloride solution as the vehicle over a prolonged period of 28 days. Trastuzumab lyophilized powder was reconstituted with water for injection to a nominal concentration of 21 mg/mL. The reconstituted trastuzumab concentrate was further diluted with 0.9 % sodium chloride solution in polypropylene infusion bags. The physicochemical stability of the infusion solutions was assessed over a four-week storage period. Test solutions were stored under refrigeration (2°C to 8°C) or at room temperature under light protection and exposed to light. Samples of test solutions were withdrawn on day 0 (initial), 1, 3, 7, 14, 21, and 28. Preparation of the test solutions and sampling were conducted under aseptic conditions. Stability of trastuzumab infusion solutions was determined by size-exclusion high-performance liquid chromatography, ultraviolet-visible spectrometry, and sodium dodecyl sulphate polyacrylamide gel electrophoresis. In addition, pH values were measured weekly over the storage period, and test solutions were visually examined for potential color changes, turbidity, or particulate matter. The stability tests used revealed that in ready-to administer trastuzumab infusion solutions (0.4 mg/mL, 4 mg/mL) trastuzumab concentrations remained above 90% of the initial concentrations, independent of the storage conditions. No degradation products were observed. Exposure to daylight did not affect the stability of the trastuzumab test solutions. Readyto-administer trastuzumab infusion solutions prepared with 0.9% sodium chloride solution in polypropylene bags are storable over a four-week period, even when stored at room temperature without light protection. For microbiological reasons, storage under refrigeration is recommended.

Related Keywords: Jeanette Kaiser, PhD, Irene Kramer, PhD, trastuzumab, stability, monoclonal antibody, infusion solutions, microbial contamination, storage conditions

Related Categories: CANCER AND AIDS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, ALLERGY/IMMUNOLOGY/INFLAMMATION, STORAGE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags
Kaiser Jeanette
, Kramer Irene
Nov/Dec 2011
Pg. 515-520

Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
May/Jun 2003
Pg. 170-174

Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Mueller Claudia
, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
May/Jun 2015
Pg. 261-267

pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes
Jappinen Annaliisa L
, Kokki H, Rasi A S, Naaranlahti Toivo J
Nov/Dec 2002
Pg. 471-474

Stability of Ertapenem in an Elastomeric Infusion Device
Phipps Stephen D
, Peacock Gina F, Smith Douglas L
May/Jun 2011
Pg. 252-254

Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions
Roy Julie
, Brault Julie, Joran Pierre, Metrop Raphael, Hildgen Patrice
Sep/Oct 2011
Pg. 428-434

Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja
, Krämer Irene, Kamin Wolfgang
May/Jun 2013
Pg. 254-261

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags
Lebrun John
, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M
Mar/Apr 2004
Pg. 156-159

Extended Stability of Oxytocin in Common Infusion Solutions
Trissel Lawrence A
, Zhang Yanping, Douglass Kate, Kastango Eric
Mar/Apr 2006
Pg. 156-158

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions